Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Eli Lilly, Novo
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity. Novo’s GLP-1 drug, Wegovy (semaglutide),
Novo beats Eli Lilly in Q3 sales for obesity drug
Novo Nordisk (NVO) reported better than expected sales for its weight loss therapy Wegovy with its Q3 2024 financials on Wednesday after Eli Lilly (LLY), its rival in the obesity drug market, posted a rare quarterly miss for its GLP-1 drug,
Mounjaro's Sales Likely To Rise 2.5x Driving Eli Lilly's Q3 Performance
The pharmaceutical giant is expected to garner $12.1 billion in sales and $1.45 in adjusted earnings per share, per the consensus estimates.
2h
on MSN
Eli Lilly set to snap six straight sessions of losses
Eli Lilly (NYSE:LLY) shares were on track to snap six straight sessions of losses on Thursday, as the stock rose 1.9% at $790 ...
1d
on MSN
Eli Lilly Posts a Huge Earnings Miss. Should Investors Be Worried?
Eli
Lilly
's business is growing fast, but it wasn't enough for analysts and investors. It also slashed its earnings ...
BizTimes
6h
Eli Lilly buys another 31 acres in Kenosha County
Indianapolis-based pharmaceutical giant Eli Lilly and Company has purchased 30.9 acres of vacant land to the north and to the ...
8d
on MSN
Eli Lilly stock tumbles after drug giant misses estimates and slashes profit guidance
Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase ...
6d
Why Eli Lilly Is a No-Brainer Stock to Buy on the Dip
Even with this partial rebound,
Lilly
's share price remains roughly 13% below the peak set in late August. Some investors ...
salisburypost
18h
RCCC benefits from involvement with Eli Lilly and Company’s Global Day of Service
RCCC News Service SALISBURY — Rowan-Cabarrus Community College and its students recently benefited from involvement with Eli Lilly and Company and its annual Global Day of Service. Student ...
8d
on MSN
Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still fell short
Eli Lilly' s blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro posted weaker-than-expected sales for the ...
The Associated Press - Business News on MSN
8d
Eli Lilly’s third quarter earnings miss and forecast cut lead to sharp stock drop
Eli Lilly is dialing back its 2024 forecast after underwhelming Wall Street with third-quarter earnings and sales from two ...
6d
Eli Lilly grows Milwaukee-area footprint with $40.8M warehouse acquisition — and more
Lilly (NYSE: LLY) makes drugs including Mounjaro for type 2 diabetes and Zepbound for obesity. For 2023, it reported $34 ...
9h
What Makes Eli Lilly & Co (LLY) a Prospective Investment?
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Large Cap Growth Strategy” third quarter 2024 investor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Novo Nordisk
Zepbound
Mounjaro
Wegovy
Vikings
Feedback